# Protara Therapeutics (TARA) — News

TARA · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/tara/news

## Recent headlines

- [Protara Therapeutics completes enrollment of the phase 2B open-label dose confirmation phase of the THRIVE-3 registrational trial of IV choline chloride in patients on parenteral support](https://www.ainvest.com/news/protara-therapeutics-completes-enrollment-phase-2b-open-label-dose-confirmation-phase-thrive-3-registrational-trial-iv-choline-chloride-patients-parenteral-support-2610) — AInvest Wire, Oct 15, 2026
- [Protara Therapeutics - on track to report interim results from Thrive-3 trial in Q4 2026](https://www.ainvest.com/news/protara-therapeutics-track-report-interim-results-thrive-3-trial-q4-2026-2608) — AInvest Wire, Aug 11, 2026
- [Protara Therapeutics announces second quarter 2026 financial results and provides a business update](https://www.ainvest.com/news/protara-therapeutics-announces-quarter-2026-financial-results-business-update-2608) — AInvest Wire, Aug 11, 2026

---

Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).